‘The HemOnc Pulse’ Live: Controversies in MDS

Recorded at HemOnc Pulse Live in Austin, Texas on May 2–3, 2025, leading experts tackle some of the most pressing controversies in the management of myelodysplastic syndromes (MDS). Moderated by Naval Daver, MD, this dynamic panel discussion brings together top thought leaders in hematologic malignancies to debate evolving treatment standards, diagnostic challenges, and the integration of emerging therapies in clinical practice.

Topics explored include the role of hypomethylating agents in frontline therapy, risk-adapted treatment strategies, and the potential impact of novel agents such as targeted therapies and combination regimens. Panelists also share their perspectives on molecular profiling, prognostic scoring systems, and ongoing trials that could redefine the treatment landscape for MDS.